ArriVent BioPharma
$30.95
1
-$0.08-0.26% Friday 20:00
+$2.05+6.62%Friday 23:56After hours
Statistics
Day High
31.1
Day Low
30.99
52W High
35.83
52W Low
17
Volume
7,167
Avg. Volume
-
Mkt Cap
1.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.9
-1.47
-1.03
-0.6
Expected EPS
-1.039389
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-166.31MNet Income
Analyst Ratings
44.00Average Price Target
The highest estimate is 47.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
Show more...
CEO
Zhengbin Yao
Employees
77
Country
United States
ISIN
US04272N1028
Listings
0 Comments
Share your thoughts
FAQ
What is ArriVent BioPharma stock price today?▼
The current price of AVBP is $30.95 USD — it has decreased by -0.26% in the past 24 hours. Watch ArriVent BioPharma stock price performance more closely on the chart.
What is ArriVent BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ArriVent BioPharma stocks are traded under the ticker AVBP.
Is ArriVent BioPharma stock price growing?▼
AVBP stock has risen by +2.59% compared to the previous week, the month change is a +1.11% rise, over the last year ArriVent BioPharma has showed a +53.29% increase.
What is ArriVent BioPharma market cap?▼
Today ArriVent BioPharma has the market capitalization of 1.53B
When is the next ArriVent BioPharma earnings date?▼
ArriVent BioPharma is going to release the next earnings report on November 18, 2026.
What were ArriVent BioPharma earnings last quarter?▼
AVBP earnings for the last quarter are -1.05 USD per share, whereas the estimation was -0.99 USD resulting in a -6.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ArriVent BioPharma revenue for the last year?▼
ArriVent BioPharma revenue for the last year amounts to 0 USD.
What is ArriVent BioPharma net income for the last year?▼
AVBP net income for the last year is -166.31M USD.
How many employees does ArriVent BioPharma have?▼
As of September 05, 2026, the company has 77 employees.
In which sector is ArriVent BioPharma located?▼
ArriVent BioPharma operates in the Health & Wellness sector.
When did ArriVent BioPharma complete a stock split?▼
ArriVent BioPharma has not had any recent stock splits.
Where is ArriVent BioPharma headquartered?▼
ArriVent BioPharma is headquartered in NEWTOWN SQUARE, United States.